CoChat

Mitochondrial permeability transition pore: sensitivity to opening and mechanistic dependence on substrate availability

Open access
Briston, Thomas, Roberts, Malcolm, Lewis, Sian, Powney, Ben, M. Staddon, James, Szabadkai, Gyorgy, Duchen, Michael R. · 2017 · Scientific Reports

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Abstract

Mitochondrial Ca 2+ uptake has a key role in cellular Ca 2+ homeostasis. Excessive matrix Ca 2+ concentrations, especially when coincident with oxidative stress, precipitate opening of an inner mitochondrial membrane, high-conductance channel: the mitochondrial permeability transition pore (mPTP). mPTP opening has been implicated as a final cell death pathway in numerous diseases and therefore understanding conditions dictating mPTP opening is crucial for developing targeted therapies. Here, we have investigated the impact of mitochondrial metabolic state on the probability and consequences of mPTP opening. Isolated mitochondria were energised using NADH- or FADH 2 -linked substrates. The functional consequences of Ca 2+ -induced mPTP opening were assessed by Ca 2+ retention capacity, using fluorescence-based analysis, and simultaneous measurements of mitochondrial Ca 2+ handling, membrane potential, respiratory rate and production of reactive oxygen species (ROS). Succinate-induced, membrane potential-dependent reverse electron transfer sensitised mitochondria to mPTP opening. mPTP-induced depolarisation under succinate subsequently inhibited reverse electron transfer. Complex I-driven respiration was reduced after mPTP opening but sustained in the presence of complex II-linked substrates, consistent with inhibition of complex I-supported respiration by leakage of matrix NADH. Additionally, ROS generated at complex III did not sensitise mitochondria to mPTP opening. Thus, cellular metabolic fluxes and metabolic environment dictate mitochondrial functional response to Ca 2+ overload.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-10673-8

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Mitochondrial metabolic substrate determines sensitivity to Ca2+-induced mPTP opening. Mitochondria (1 mg protein ml−1) were incubated with Fluo-4FF (0.35 μM) or TMRM (2 μM) in the presence of either glutamate/malate (10 mM/2 mM), succinate (10 mM) or succinate/rotenone (10 mM/1 μM). Pulses of CaCl2 (10 μM) were added sequentially and fluorescence measured. (a) Trace of extracellular Ca2+ fluorescence (using Fluo-4FF) and Ca2+ uptake in the presence different metabolic substrates prior to mPTP opening. Data was normalised using baseline and maximal Fluo-4FF fluorescence. (b) Trace of TMRM fluorescence and time-dependent transmembrane depolarisation after Ca2+ overloading and mPTP opening using different metabolic substrates. Data was normalised to baseline and maximal TMRM fluorescence (maximal depolarisation/maximal TMRM de-quench). (c) Area under the curve using Fluo-4FF calculated between CaCl2 injection numbers 4 and 5. Data were analysed using one-way ANOVA corrected for multiple comparisons using Holm-Sidak method. (d) Area under the curve using TMRM, calculated between CaCl2 injection numbers 4 and 5. Data were analysed using one-way ANOVA, corrected for multiple comparisons using Holm-Sidak method. Data are expressed as means with error bars indicating standard deviation of 6 independent experiments. (e) Fluo-4FF trace from (a), showing deviation of response as a function of glutamate/malate and (f) TMRM trace from (b) showing deviation of response as a function of succinate. ns; P > 0.05, *P = 0.01–0.05, **P = 0.001–0.01, ***P < 0.001. Abbreviations: ns; not significant, CsA; cyclosporin A, TMRM; tetramethylrhodamine methylester, a.u; arbitrary unit, AUC; area under the curve.
Figure 1 Mitochondrial metabolic substrate determines sensitivity to Ca2+-induced mPTP opening. Mitochondria (1 mg protein ml−1) were incubated with Fluo-4FF (0.35 μM) or TMRM (2 μM) in the presence of either glutamate/malate (10 mM/2 mM), succinate (10 mM) or succinate/rotenone (10 mM/1 μM). Pulses of CaCl2 (10 μM) were added sequentially and fluorescence measured. (a) Trace of extracellular Ca2+ fluorescence (using Fluo-4FF) and Ca2+ uptake in the presence different metabolic substrates prior to mPTP opening. Data was normalised using baseline and maximal Fluo-4FF fluorescence. (b) Trace of TMRM fluorescence and time-dependent transmembrane depolarisation after Ca2+ overloading and mPTP opening using different metabolic substrates. Data was normalised to baseline and maximal TMRM fluorescence (maximal depolarisation/maximal TMRM de-quench). (c) Area under the curve using Fluo-4FF calculated between CaCl2 injection numbers 4 and 5. Data were analysed using one-way ANOVA corrected for multiple comparisons using Holm-Sidak method. (d) Area under the curve using TMRM, calculated between CaCl2 injection numbers 4 and 5. Data were analysed using one-way ANOVA, corrected for multiple comparisons using Holm-Sidak method. Data are expressed as means with error bars indicating standard deviation of 6 independent experiments. (e) Fluo-4FF trace from (a), showing deviation of response as a function of glutamate/malate and (f) TMRM trace from (b) showing deviation of response as a function of succinate. ns; P > 0.05, *P = 0.01–0.05, **P = 0.001–0.01, ***P < 0.001. Abbreviations: ns; not significant, CsA; cyclosporin A, TMRM; tetramethylrhodamine methylester, a.u; arbitrary unit, AUC; area under the curve.CC BY · PubMed Central
Figure 2 Mitochondrial metabolic substrate determines bioenergetic response to Ca2+-induced mPTP opening. Representative oxygen flux recording using closed-chamber, high-resolution respirometry. Mitochondria (1 mg protein ml−1) were maintained in the presence of either (a,b) glutamate/malate (10 mM/2 mM), (c,d) succinate (10 mM) or (e,f) succinate/rotenone (10 mM/1 μM) under constant stirring. Sequential additions of CaCl2 (2.5 μM) were added as indicated to induce mPTP opening. Oxygen consumption (blue trace) and extra-mitochondrial Ca2+ fluorescence (a,c,e) Fluo-4FF; green trace) or ΔΨm (b,d,f): TMRM; red trace) were measured in parallel using the Oxygraph 2 K equipped with fluorimeter and fluorescent control unit (Oroboros Instruments, Innsbruck, Austria). Antimycin A (2.5 μM) was used to completely inhibit respiration. Traces are representative of at least 3 independent experiments. Abbreviations: TMRM; tetramethylrhodamine methylester, AA; antimycin A.
Figure 2 Mitochondrial metabolic substrate determines bioenergetic response to Ca2+-induced mPTP opening. Representative oxygen flux recording using closed-chamber, high-resolution respirometry. Mitochondria (1 mg protein ml−1) were maintained in the presence of either (a,b) glutamate/malate (10 mM/2 mM), (c,d) succinate (10 mM) or (e,f) succinate/rotenone (10 mM/1 μM) under constant stirring. Sequential additions of CaCl2 (2.5 μM) were added as indicated to induce mPTP opening. Oxygen consumption (blue trace) and extra-mitochondrial Ca2+ fluorescence (a,c,e) Fluo-4FF; green trace) or ΔΨm (b,d,f): TMRM; red trace) were measured in parallel using the Oxygraph 2 K equipped with fluorimeter and fluorescent control unit (Oroboros Instruments, Innsbruck, Austria). Antimycin A (2.5 μM) was used to completely inhibit respiration. Traces are representative of at least 3 independent experiments. Abbreviations: TMRM; tetramethylrhodamine methylester, AA; antimycin A.CC BY · PubMed Central
Figure 3 Respiratory consequences of mPTP opening are sensitive to mPTP inhibitors. Representative oxygen flux recording using closed-chamber, high-resolution respirometry. (a) Mitochondria (1 mg protein ml−1) were maintained in the presence of glutamate/malate (10 mM/2 mM) under constant stirring. CsA (0.5 μM) and RuR (0.5 μM) were added after baseline stabilisation. Percentage change in respiration was calculated after 5 minutes compound incubation. Data are expressed as means with error bars indicating standard deviation of at least three independent experiments. Data was analysed using one-way ANOVA, corrected for multiple comparisons using Holm-Sidak method. (b–e) Mitochondria were incubated as above and parallel measurements of oxygen consumption (blue trace) and either extra-mitochondrial Ca2+ (Fluo-4FF; green trace) or membrane potential (TMRM; red trace)were measured using the Oxygraph 2 K equipped with fluorimeter and fluorescent control unit (Oroboros Instruments, Innsbruck, Austria). Mitochondria were pre-treated with (b,c) CsA (0.5 μM) or (d,e) RuR (0.5 μM) prior to sequential additions of CaCl2 (2.5 μM). Abbreviations: Mito; mitochondria, TMRM; tetramethylrhodamine methylester, NADH; nicotinamide adenine dinucleotide, Succ; succinate, AA; antimycin A.
Figure 3 Respiratory consequences of mPTP opening are sensitive to mPTP inhibitors. Representative oxygen flux recording using closed-chamber, high-resolution respirometry. (a) Mitochondria (1 mg protein ml−1) were maintained in the presence of glutamate/malate (10 mM/2 mM) under constant stirring. CsA (0.5 μM) and RuR (0.5 μM) were added after baseline stabilisation. Percentage change in respiration was calculated after 5 minutes compound incubation. Data are expressed as means with error bars indicating standard deviation of at least three independent experiments. Data was analysed using one-way ANOVA, corrected for multiple comparisons using Holm-Sidak method. (b–e) Mitochondria were incubated as above and parallel measurements of oxygen consumption (blue trace) and either extra-mitochondrial Ca2+ (Fluo-4FF; green trace) or membrane potential (TMRM; red trace)were measured using the Oxygraph 2 K equipped with fluorimeter and fluorescent control unit (Oroboros Instruments, Innsbruck, Austria). Mitochondria were pre-treated with (b,c) CsA (0.5 μM) or (d,e) RuR (0.5 μM) prior to sequential additions of CaCl2 (2.5 μM). Abbreviations: Mito; mitochondria, TMRM; tetramethylrhodamine methylester, NADH; nicotinamide adenine dinucleotide, Succ; succinate, AA; antimycin A.CC BY · PubMed Central
Figure 4 Respiratory consequences of mPTP opening are rescued by exogenous NADH or succinate. (a) Mitochondria (1 mg protein ml−1) were maintained in the presence of glutamate/malate (10 mM/2 mM) under constant stirring and subject to a Ca2+ retention challenge. Following pore opening, NADH (3 mM) or (b) succinate (10 mM) were added as indicated and respiration (blue trace), Ca2+ uptake (solid red trace) and ΔΨm (dashed red trace) measured simultaneously. Antimycin A (2.5 μM) was used to inhibit all respiration. Traces are representative of at least 3 independent experiments. Abbreviations: TMRM; tetramethylrhodamine methylester, NADH; nicotinamide adenine dinucleotide, Succ; succinate, AA; antimycin A.
Figure 4 Respiratory consequences of mPTP opening are rescued by exogenous NADH or succinate. (a) Mitochondria (1 mg protein ml−1) were maintained in the presence of glutamate/malate (10 mM/2 mM) under constant stirring and subject to a Ca2+ retention challenge. Following pore opening, NADH (3 mM) or (b) succinate (10 mM) were added as indicated and respiration (blue trace), Ca2+ uptake (solid red trace) and ΔΨm (dashed red trace) measured simultaneously. Antimycin A (2.5 μM) was used to inhibit all respiration. Traces are representative of at least 3 independent experiments. Abbreviations: TMRM; tetramethylrhodamine methylester, NADH; nicotinamide adenine dinucleotide, Succ; succinate, AA; antimycin A.CC BY · PubMed Central
Figure 5 Metabolic substrate determines mitochondrial Ca2+-induced H2O2 production. Mitochondria (1 mg protein ml−1) were incubated with AmpR/HRP (10 μM/1 U ml−1) or Fluo-4FF (0.35 μM) in the presence of either glutamate/malate (10 mM/2 mM), succinate (10 mM) or succinate/rotenone (10 mM/1 μM). (a) Baseline rates of mtROS production under distinct metabolic conditions were measured using the FLIPRTETRA. Data was analysed using one-way ANOVA, corrected for multiple comparisons using Holm-Sidak method. (b) Pulses of CaCl2 (10 μM) were added sequentially and extra-mitochondria Ca2+ (Fluo-4FF; solid trace) and H2O2 (AmpR; dashed trace) recorded in parallel. Area under the curve (Fluo-4FF) and slope (AmpR) were calculated between each CaCl2 injection in mitochondrial energised using defined substrates. (c) H2O2 production calculated between CaCl2 injections 5–6 in the presence and absence of CsA (1 μM) or RuR (1 μM) to inhibit mPTP opening and Ca2+ uptake respectively. Data are normalised to baseline and are expressed as means with error bars indicating standard deviation of at least three independent experiments. Data was analysed by two-way ANOVA, corrected for multiple comparisons using Holm-Sidak method. Comparisons between groups: ns; P > 0.05, *P = 0.01–0.05, **P = 0.001–0.01 ***P < 0.001. Comparisons within groups: No symbol P > 0.05, + P = 0.01–0.05, $ P = 0.001–0.01 ^ P = 0.0001–0.001, *P < 0.0001. (d,e) Mitochondria (1 mg protein ml−1) were incubated as above in the presence of either glutamate/malate (10 mM/2 mM), succinate (10 mM) or succinate/rotenone (10 mM/1 μM). Sequential additions of CaCl2 (10 μM) were added as indicated. Mitochondria were incubated in the presence of (d) CsA and (e) RuR in a 2-fold dilution series under distinct metabolic conditions. H2O2 production was measured following CaCl2 injection 10. Data are presented as change in AmpR fluorescence over time (slope). (f) Mitochondria (1 mg protein ml−1) were incubated with AmpR/HRP (10 μM/1 U ml−1) in the presence of either glutamate/malate (10 mM/2 mM), succinate (10 mM) or succinate/rotenone (10 mM/1 μM). FCCP was added for 10 minutes and fluorescence measured. Data are presented as change in AmpR fluorescence over time (slope) normalised to data in the presence of DMSO alone. (g,h) Representative oxygen flux recording using closed-chamber, high-resolution respirometry. Mitochondria (1 mg protein ml−1) were maintained in the presence of glutamate/malate (10 mM/2 mM) under constant stirring. Sequential additions of CaCl2 (2.5 μM) were added as indicated to induce mPTP opening. Oxygen consumption (blue trace) and H2O2 production (AmpR; red trace) were recorded in parallel using the Oxygraph 2 K equipped with fluorimeter and fluorescent control unit (Oroboros Instruments, Innsbruck, Austria), in the presence of (g) CsA (0.5 μM) and (h) RuR (0.5 μM; dashed traces) to inhibit mPTP opening and Ca2+ uptake respectively. Abbreviations: Mito; mitochondria, CsA; cyclosporin A, RuR; ruthenium red, AmpR; Amplex Red, AA; antimycin A, Succ; succinate, Rot; rotenone, a.u; arbitrary unit, AUC; area under the curve, Glu; glutamate, Mal; malate.
Figure 5 Metabolic substrate determines mitochondrial Ca2+-induced H2O2 production. Mitochondria (1 mg protein ml−1) were incubated with AmpR/HRP (10 μM/1 U ml−1) or Fluo-4FF (0.35 μM) in the presence of either glutamate/malate (10 mM/2 mM), succinate (10 mM) or succinate/rotenone (10 mM/1 μM). (a) Baseline rates of mtROS production under distinct metabolic conditions were measured using the FLIPRTETRA. Data was analysed using one-way ANOVA, corrected for multiple comparisons using Holm-Sidak method. (b) Pulses of CaCl2 (10 μM) were added sequentially and extra-mitochondria Ca2+ (Fluo-4FF; solid trace) and H2O2 (AmpR; dashed trace) recorded in parallel. Area under the curve (Fluo-4FF) and slope (AmpR) were calculated between each CaCl2 injection in mitochondrial energised using defined substrates. (c) H2O2 production calculated between CaCl2 injections 5–6 in the presence and absence of CsA (1 μM) or RuR (1 μM) to inhibit mPTP opening and Ca2+ uptake respectively. Data are normalised to baseline and are expressed as means with error bars indicating standard deviation of at least three independent experiments. Data was analysed by two-way ANOVA, corrected for multiple comparisons using Holm-Sidak method. Comparisons between groups: ns; P > 0.05, *P = 0.01–0.05, **P = 0.001–0.01 ***P < 0.001. Comparisons within groups: No symbol P > 0.05, + P = 0.01–0.05, $ P = 0.001–0.01 ^ P = 0.0001–0.001, *P < 0.0001. (d,e) Mitochondria (1 mg protein ml−1) were incubated as above in the presence of either glutamate/malate (10 mM/2 mM), succinate (10 mM) or succinate/rotenone (10 mM/1 μM). Sequential additions of CaCl2 (10 μM) were added as indicated. Mitochondria were incubated in the presence of (d) CsA and (e) RuR in a 2-fold dilution series under distinct metabolic conditions. H2O2 production was measured following CaCl2 injection 10. Data are presented as change in AmpR fluorescence over time (slope). (f) Mitochondria (1 mg protein ml−1) were incubated with AmpR/HRP (10 μM/1 U ml−1) in the presence of either glutamate/malate (10 mM/2 mM), succinate (10 mM) or succinate/rotenone (10 mM/1 μM). FCCP was added for 10 minutes and fluorescence measured. Data are presented as change in AmpR fluorescence over time (slope) normalised to data in the presence of DMSO alone. (g,h) Representative oxygen flux recording using closed-chamber, high-resolution respirometry. Mitochondria (1 mg protein ml−1) were maintained in the presence of glutamate/malate (10 mM/2 mM) under constant stirring. Sequential additions of CaCl2 (2.5 μM) were added as indicated to induce mPTP opening. Oxygen consumption (blue trace) and H2O2 production (AmpR; red trace) were recorded in parallel using the Oxygraph 2 K equipped with fluorimeter and fluorescent control unit (Oroboros Instruments, Innsbruck, Austria), in the presence of (g) CsA (0.5 μM) and (h) RuR (0.5 μM; dashed traces) to inhibit mPTP opening and Ca2+ uptake respectively. Abbreviations: Mito; mitochondria, CsA; cyclosporin A, RuR; ruthenium red, AmpR; Amplex Red, AA; antimycin A, Succ; succinate, Rot; rotenone, a.u; arbitrary unit, AUC; area under the curve, Glu; glutamate, Mal; malate.CC BY · PubMed Central
Figure 6 Mitochondrial metabolic substrate determines H2O2 production in response to mitochondrially-active compounds. Mitochondria (1 mg protein ml−1) were incubated with AmpR/HRP (10 μM/1 U ml−1) in the presence of either (A) glutamate/malate (10 mM/2 mM), (B) succinate (10 mM) or (C) succinate/rotenone (10 mM/1 μM). Mitochondria were subject to Ca2+ retention assay and 10 pulses of CaCl2 (10 μM) were added sequentially over time. H2O2 production was measured following the addition of mitochondrially-active compounds. Mitochondrially-active compounds were incubated for 10 minutes and fluorescence measured. CsA (1 μM) and RuR (1 μM) were included to inhibit mPTP opening and Ca2+ uptake respectively. Data are expressed as means with error bars indicating standard deviation of at least three independent experiments, normalised to vehicle (DMSO). Data was analysed using two-way ANOVA, corrected for multiple comparisons using Holm-Sidak method. No symbol P > 0.05, + P = 0.01–0.05, $ P = 0.001–0.01, ^ P = 0.0001–0.001, *P < 0.0001. Abbreviations: CsA; cyclosporin A, RuR; ruthenium red, Glu; glutamate, Mal; malate, Succ; succinate, Rot; rotenone, AmpR; Amplex Red.
Figure 6 Mitochondrial metabolic substrate determines H2O2 production in response to mitochondrially-active compounds. Mitochondria (1 mg protein ml−1) were incubated with AmpR/HRP (10 μM/1 U ml−1) in the presence of either (A) glutamate/malate (10 mM/2 mM), (B) succinate (10 mM) or (C) succinate/rotenone (10 mM/1 μM). Mitochondria were subject to Ca2+ retention assay and 10 pulses of CaCl2 (10 μM) were added sequentially over time. H2O2 production was measured following the addition of mitochondrially-active compounds. Mitochondrially-active compounds were incubated for 10 minutes and fluorescence measured. CsA (1 μM) and RuR (1 μM) were included to inhibit mPTP opening and Ca2+ uptake respectively. Data are expressed as means with error bars indicating standard deviation of at least three independent experiments, normalised to vehicle (DMSO). Data was analysed using two-way ANOVA, corrected for multiple comparisons using Holm-Sidak method. No symbol P > 0.05, + P = 0.01–0.05, $ P = 0.001–0.01, ^ P = 0.0001–0.001, *P < 0.0001. Abbreviations: CsA; cyclosporin A, RuR; ruthenium red, Glu; glutamate, Mal; malate, Succ; succinate, Rot; rotenone, AmpR; Amplex Red.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 64 references

Cited by

See all 159

Metadata

Authors
Briston, T., Roberts, M., Lewis, S., Powney, B., M. Staddon, J., Szabadkai, G., & Duchen, M. R.
Affiliations
  • Eisai (United Kingdom) (GB)
  • University College London (GB)
Corresponding author
Briston, Thomas
Venue
Scientific Reports
Published
2017-09-05
Volume
7
Issue
1
Pages
10492-10492
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2753044726
Cited by
152
References
64
Citations by year
2026: 11 · 2025: 9 · 2024: 18 · 2023: 14 · 2022: 17 · 2021: 31 · 2020: 26 · 2019: 18 · 2018: 8
FWCI
5.81
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion, cc-by)
Funders
Eisai
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › ATP Synthase and ATPases Research
Keywords
mitochondrial permeability transition pore, mitochondrial calcium uptake, calcium retention capacity, reverse electron transfer, succinic acid, mitochondrial membrane potential, reactive oxygen species, oxidative stress, mitochondrial calcium overload, cell death
MeSH terms
Mitochondrial Permeability Transition Pore, Animals, Calcium, Energy Metabolism, Female, Hydrogen Peroxide, Mitochondria, NAD, Oxygen Consumption, Ion Channel Gating, Reactive Oxygen Species, Cell Respiration, Succinic Acid, Mitochondrial Membrane Transport Proteins, Electron Transport Complex I, Rats, Membrane Potential, Mitochondrial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mitochondrial permeability transition pore: sensitivity to opening and mechanistic dependence on substrate availability. https://app.cochat.ai/papers/10.1038/s41598-017-10673-8
The paper
Briston, T., Roberts, M., Lewis, S., Powney, B., M. Staddon, J., Szabadkai, G., & Duchen, M. R. (2017). Mitochondrial permeability transition pore: sensitivity to opening and mechanistic dependence on substrate availability. Scientific Reports. https://doi.org/10.1038/s41598-017-10673-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.